Namrata Bhutani (2024) “Targeted Therapy for CML Patients on Imatinib: Role of Novel Variants of Human Organic Cationic Transporter 1 (hOCT1)”, Disease and Health Research: New Insights Vol. 3, pp. 81–87. doi: 10.9734/bpi/dhrni/v3/1656.